Emergency department of university hospital Fattouma Bourguiba of Monastir
Monastir, 6000, Tunisia
NCT Number: NCT02142985
Vascular filling is the main treatment of hypovolemia. Hypovolemia diagnosis can be difficult in some situations and need to be confirmed with other investigations.
Venous oxymetry based on the ScvO2 values represent a valuable way to predict responsivness to fluid filling maneuver in patients with hemodynamic instability.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 2
Monastir, 6000, Tunisia
Vascular filling represent the milestone of the treatment of hypovolemia. Its main objective is to restore vascular volume and correct perfusion issues preventing the deleterious consequences of prolonged shock.
Hypovolemia diagnosis is easy to made in obvious clinical situations such as hemorrhagic shock, deshydratation..., but there still many diagnostic difficulties regarding latent hypovolemia especially if associated with left ventricular dysfunction.
In this situations, diagnostic of hypovolemia is hard to made and other investigations are needed.
Central venous pressure (CVP) and pulmonary occlusion artery pressure (PAPO) are the mainly used parameters for indicating vascular filling but actually many studies underline their low liability in this situation.
After vascular filling, outcome measurment is needed to evaluate the efficacity of the treatment.
Outcome measurment based on hemodynamic criteria is still insufficient. In fact, tissue hypoxia persists if the cardio - respiratory system did not adapt to the metabolic needs, that's why a pathway based on therapeutic objectives like venous oxymetry is needed.
Theorically, a filling maneuver is beneficial if associated with a ScvO2 amelioration. It reflects the amelioration of cardiac output and predicts the positive responsivness to the filling test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vascular filling with 500 ml of crystalloid solution (sodium chloride 0.9%) over 30 minutes
Time frame: at baseline and after 10 minutes
the ScvO2 is first measured at baseline via a central venous catheter and blood gaz, then after vascular filling (500 ml of colloid solution (Plasmagel) over thirty minutes).
University of Monastir
Other
Acronym: VOS-HI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06043505
Hemodynamic Instability, Infections
Nîmes, France
View Trial DetailsNCT05705115
Fluid Loss, Hemodynamic Instability
Oslo, Norway
View Trial DetailsNCT06270485
Cardiovascular Abnormalities, Cardiovascular Diseases
Berlin, State of Berlin, Germany
View Trial DetailsNCT07493811
Hemodynamic Instability, Hypoxemia
Beşiktaş, İ̇stanbul, Turkey (Türkiye)
View Trial Details